Rodgers & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Sell |
496
-23
| -4% | -$9.33K | 0.02% | 102 |
|
|
2025
Q1 | $258K | Sell |
519
-57
| -10% | -$28.4K | 0.03% | 80 |
|
|
2024
Q4 | $300K | Sell |
576
-10
| -2% | -$5.2K | 0.04% | 77 |
|
|
2024
Q3 | $362K | Buy |
586
+10
| +2% | +$6.19K | 0.04% | 76 |
|
|
2024
Q2 | $319K | Buy |
576
+190
| +49% | +$105K | 0.04% | 75 |
|
|
2024
Q1 | $224K | Sell |
386
-110
| -22% | -$63.9K | 0.03% | 80 |
|
|
2023
Q4 | $263K | Sell |
496
-68
| -12% | -$36.1K | 0.04% | 77 |
|
|
2023
Q3 | $285K | Buy |
+564
| New | +$285K | 0.04% | 74 |
|
|
2023
Q2 | – | Sell |
-369
| Closed | -$213K | – | 86 |
|
|
2023
Q1 | $213K | Sell |
369
-90
| -20% | -$51.9K | 0.03% | 83 |
|
|
2022
Q4 | $253K | Sell |
459
-30
| -6% | -$16.5K | 0.04% | 74 |
|
|
2022
Q3 | $248K | Hold |
489
| – | – | 0.04% | 72 |
|
|
2022
Q2 | $266K | Sell |
489
-225
| -32% | -$122K | 0.05% | 76 |
|
|
2022
Q1 | $422K | Sell |
714
-45
| -6% | -$26.6K | 0.06% | 68 |
|
|
2021
Q4 | $506K | Buy |
+759
| New | +$506K | 0.08% | 67 |
|